My Account

Non-Alcoholic Fatty Liver Disease (NAFLD)

NAFLD is the accumulation of fat in the liver not caused by alcohol use, closely linked to insulin resistance and type 2 diabetes; left unaddressed, it can progress to non-alcoholic steatohepatitis (NASH), fibrosis, and cirrhosis. This page covers the three steps of working with NAFLD in one place — metabolic diagnostics, the correction protocol, and the format of the online consultation.

The workup uses a panel of 50+ biomarkers: liver enzymes (ALT, AST, GGT), a full lipid profile, insulin resistance markers (fasting insulin, HOMA-IR), inflammation markers, and common deficiencies (vitamin D, ferritin) that compound metabolic dysfunction in NAFLD.

Most patients arrive with only ALT/AST checked, which can stay within normal range even when significant liver fat and insulin resistance are already present. Because NAFLD is driven upstream by insulin resistance rather than by the liver alone, a single-marker liver panel misses the mechanism that actually needs to be addressed.

Where you are

CyprusIndiaUAEOnline (worldwide)United Kingdom (online)United States (online)

Frequently asked questions

Готовы начать?

Записаться на консультацию